Start date for UPC postponed to 1 June 2023 and sunrise period for opt-out to 1 March 2023

The UPC website has announced today that the start date for the sunrise period will be delayed until 1 March 2023 to allow users to prepare themselves for the strong authentication required to access the UPC's case management system (CMS) and to sign documents.  Previously the sunrise period was due to start on 1 January 2023.  This delay means that that start date for the UPC will also be pushed back by two months, to 1 June 2023 (rather than 1 April). The UPC site says that no further delay is anticipated. This June start date would require Germany to deposit its instrument of ratification of the UPC Agreement in February. Read more

HSF shares insights on the Milan local division UPC judges for Managing IP

Following the Unified Patent Court (UPC) Administrative Committee's appointment of 85 legal and technical judges last month, including the appointment of two legally qualified judges in the Milan local division, Herbert Smith Freehills' Joint Global Head of Intellectual Property Laura Orlando shares her insights with Managing IP on what this may mean for the UPC. Read more

New website launched for the Unified Patent Court (UPC)

The Unified Patent Court has launched its official website today, replacing the UPC Preparatory Committee's original site at the same address: www.unified-patent-court.org.  The new website carries links to all the key legal documents establishing the Court and to the Procedural Rules, as well as information on the Court and Registry. Read more

HSF comments for JUVE Patent on UPC judges list announcement

On 19 October 2022, the Unified Patent Court (UPC) Administrative Committee announced the appointment of 85 legal and technical judges, ready for when the UPC Agreement comes into force, likely in Spring 2023 (1 April 2023 as per the latest announcement from the UPC Administrative Committee). Milan-based Joint Global Head of Intellectual Property, Laura Orlando, discusses the latest announcement with Amy Sandys at JUVE Patent in the article UPC divisions demonstrate clout with choice of experienced legal judges. Read more

Update on the Teva Copaxone EU case. The EU Commission issues a Statement of Objections against Teva over alleged anti-competitive conduct consisting of misuse of divisional patents and a disparagement campaign against its closest competitor

On 10 October 2022, the European Commission (“EU Commission“) formally adopted a Statement of Objections (“SO“) against Teva over an alleged abuse of dominance concerning its blockbuster drug Copaxone, which is used in the treatment of multiple sclerosis. As we reported in March 2021, the EU Commission was investigating for the first time a company … Read more

HSF comments for IAM on The UPC on Day 1

Laura Orlando and Rachel Montagnon were in conversation with Adam Houldsworth of IAM recently, leading to their comments being published in the IAM article "Your guide to the UPC on day one". Access the article and their quotes here. Read more